Patient-Oriented Application of New Monoclonal Antibodies for Severe Asthma
Journal Title: Turkish Journal of Immunology - Year 2018, Vol 6, Issue 3
Abstract
Asthma is a chronic lung disease that occurs due to many genetic and environmental factors. In the Global Initiative for Asthma (GINA) guideline, anti-immunoglobulin E (anti-IgE) (omalizumab) for patients with allergic asthma, anti-interleukin-5 (mepolizumab and reslizumab) or anti-interleukin 5 receptor (benralizumab) for patients with severe eosinophilic asthma are recommended as add-on treatment if the patients remain uncontrolled on STEP-4 treatment. Omalizumab, a humanized monoclonal antibody, inhibits the immunologic effects of immunoglobulin E (IgE) that binds to circulating high affinity IgE receptor. Mepolizumab acts by binding to interleukin-5 (IL-5), a cytokine required for the development of eosinophils, and reduces eosinophil levels. Although the mechanisms of action are similar, the magnitude of the patient’s airway inflammation, the severity of the disease, and the phenotypic differences of the patients may be important for the treatment decisions. Even though in GINA, omalizumab is recommended as add-on treatment in STEP-5 for ≥6 years of age moderate to severe allergic asthma, in our country it was approved for the same phenotypic patients who were over 12 years of age. Both clinical trials and real world experience data support efficacy and safety of omalizumab for the treatment of moderate-to-severe allergic asthma. Evidence for clinical use in non allergic asthma as well as other investigational uses are already limited. Keywords: Asthma, immunoglobulin E, mepolizumab, omalizumab
Authors and Affiliations
Ender COŞKUNPINAR, Çağla TARIM, Ceyda HAYRETDAĞ ÖRS, İlkim DİNÇOL, Noor Muhammad MAKHDOMİ, Mohamed NİANG, Pınar YILDIZ
Keywords
Related Articles
- EP ID EP450960
- DOI 10.25002/tji.2018.858
- Views 77
- Downloads 0
The Significant Effect of Conditioned Medium of Umbilical Cord Mesenchymal Stem Cells in Histological Improvement of Cartilage Defect in Wistar Rats
Introduction: Mesenchymal stem cells are multipotent cells present in multiple tissues that have potential for future disease treatment including cartilage damage. This study was aimed to investigate the effect of condit...
The Relationship Between Serum Vitamin D (25(OH)D3), C-Peptide, and Interleukin-2 Level in Children with Type 1 Diabetes Mellitus
Introduction: Vitamin D is very important for Type 1 diabetes mellitus (T1 DM) pathogenesis, and plays major role in the regulation of pancreatic beta cells. However, serum vitamin D (25(OH)D3) level related to inflammat...
Patient-Oriented Application of New Monoclonal Antibodies for Severe Asthma
Asthma is a chronic lung disease that occurs due to many genetic and environmental factors. In the Global Initiative for Asthma (GINA) guideline, anti-immunoglobulin E (anti-IgE) (omalizumab) for patients with allergic a...
The Effect of Lactobacillus reuteri on the Percentage of Th17 Cells and Level of IL-17 in Staphylococcus aureus-Induced Puerperal Infection BALB/c Mice
Background: Puerperal infection is an infection of the reproductive tract during labor or puerperal period, which is largely caused by Staphylococcus aureus infection resulting in Toxic Shock Syndrome (TSS). The prevalen...
Identification of Hemagglutinin Protein from Streptococcus pneumoniae Pili as a Vaccine Candidate by Proteomic Analysis
Introduction: Streptococcus pneumoniae is a Gram-positive, bacterial human pathogen that causes a large number of respiratory tract infections, such as pneumonia and sinusitis, as well as invasive diseases such as septic...